Trial Profile
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2010
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Pioglitazone (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Jun 2010 Results published in Metabolism - Clinical and Experimental.